CRITICS-II: Preoperative Chemotherapy + Chemoradiotherapy May Improve Outcomes in Patients With Resectable Gastric Cancer

Default Digital Object Group 2026 Dataset

View at publisher
DOI: 10.1200/adn.26.300305
Cited by: 0

Abstract

Neoadjuvant chemotherapy plus chemoradiotherapy may be superior to neoadjuvant chemotherapy or chemoradiotherapy alone in patients with resectable gastric cancer, according to results from the phase 2 CRITICS-II trial conducted in the Netherlands (Abstract 283).

Publication details

Journal / source
Default Digital Object Group
Publication date
8 January 2026
Document type
Dataset